BLOG

Sunday, March 3, 2019

Aurobindo Pharma acquires 7 oncology products from US company for $300 mn

The product portfolio is expected to generate a revenue of around $100 million for first 12 months after completion of the transaction for Aurobindo

from Home Page https://ift.tt/2EGNQru
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...